NCT06897319View on ClinicalTrials.gov

High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 20, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions
Tracheostomized Patients
Interventions
DEVICE

High-Flow Tracheal Therapy

Device: Airvo 2 (Fisher \& Paykel Healthcare) Settings: Flow rate start at 40L/min and will be adapted according to tolerance; temperature aimed at 37°C or 34°C according to tolerance, FiO₂ set (if needed) according to SpO2 target values.

Trial Locations (1)

1200

Cliniques universitaires Saint-Luc, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT06897319 - High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients | Biotech Hunter | Biotech Hunter